Junqing Liang
Peking University(CN)Peking University Cancer Hospital(CN)Second Affiliated Hospital of Inner Mongolia Medical University(CN)Peking University People's Hospital(CN)Hua Medicine (China)(CN)Inner Mongolia Medical University(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Immune Cell Function and Interaction, Dialysis and Renal Disease Management, Cancer-related molecular mechanisms research, Virus-based gene therapy research
Most-Cited Works
- → Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy(2014)151 cited
- → Role of MicroRNA-30c in cancer progression(2020)62 cited
- → Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer(2022)51 cited
- → Single cell whole genome sequencing reveals that NFKB1 mutation affects radiotherapy sensitivity in cervical cancer(2017)22 cited
- → Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma(2023)20 cited
- → Risk factors and prevalence of cognitive impairment in maintenance haemodialysis patients: A systematic review and meta‐analysis of observational studies(2023)17 cited